This interventional study aims to evaluate the effectiveness of an educational program on women's knowledge of Human Papillomavirus (HPV), HPV vaccination, and screening. HPV is a major public health concern worldwide and a leading cause of cervical cancer. Although cervical cancer is preventable through vaccination and early screening, HPV awareness among women remains limited in Türkiye. Educational interventions are therefore essential to improve knowledge and promote preventive health behaviors. The study population consists of 110 women attending courses at the Suzan and Abdulhakim Bilgili Public Education Center in Onikişubat, Kahramanmaraş, Türkiye, between August 2025 and December 2025. No formal sample size calculation was performed. Instead, 80 women who met the inclusion criteria and voluntarily agreed to participate were included in the study. Participants were randomly assigned to either the intervention group (education) or the control group (no education). The HPV education program is delivered in two 1-hour sessions using PowerPoint presentations and informational brochures developed from current literature and reviewed by experts in women's health nursing. Data are collected before and after the educational sessions using a Personal Information Form and the HPV Knowledge Scale (HPV-KS), which measures participants' knowledge about HPV infection, vaccination, and screening. Statistical analyses will be conducted using SPSS 22.0, with descriptive statistics and inferential tests (paired-sample t-test, independent-sample t-test, repeated-measures ANOVA, and non-parametric equivalents) applied as appropriate. A p-value \< 0.05 will be considered statistically significant. It is hypothesized that women receiving HPV education will demonstrate significantly higher post-intervention knowledge scores compared to those in the control group.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
HPV knowledge level measured by the Human Papillomavirus Knowledge Scale (HPV-BÖ)
Timeframe: Baseline (pre-test) and immediately after the education session (post-test)